Jeremy Grantham Medpace Holdings, Inc. Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$30.8 Billion
Q1 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 22,010 shares of MEDP stock, worth $9.85 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

22,010

Previous 17,192 28.02%

Holding current value

$9.85 Million

Previous $5.71 Million 17.42%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$304.69 - $360.97 $1.47 Million - $1.74 Million	4,818 Added 28.02%	22,010 $6.71 Million
Q4 2024 Feb 13, 2025	BUY	$308.93 - $363.58 $5.31 Million - $6.25 Million	17,192 New	17,192 $5.71 Million
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $1.28 Million - $1.46 Million	3,432 Added 9.86%	38,237 $15.7 Million
Q1 2024 May 14, 2024	SELL	$284.87 - $413.31 $4.77 Million - $6.93 Million	-16,760 Reduced 32.5%	34,805 $14.1 Million
Q4 2023 Feb 13, 2024	SELL	$227.52 - $312.68 $556,058 - $764,189	-2,444 Reduced 4.53%	51,565 $15.8 Million
Q3 2023 Nov 13, 2023	BUY	$233.98 - $281.67 $2.02 Million - $2.43 Million	8,635 Added 19.03%	54,009 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $8.5 Million - $10.9 Million	45,374 New	45,374 $10.9 Million
Q1 2019 May 14, 2019	SELL	$49.38 - $70.58 $617,250 - $882,250	-12,500 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$43.25 - $63.74 $294,100 - $433,432	-6,800 Reduced 35.23%	12,500 $749,000
Q2 2018 Aug 14, 2018	BUY	$34.03 - $45.46 $23,821 - $31,822	700 Added 3.76%	19,300 $830,000
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $595,758 - $726,330	18,600 New	18,600 $649,000

Others Institutions Holding MEDP

# of Institutions

632

Shares Held

25.7M

Call Options Held

47K

Put Options Held

80.8K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $13.9B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account